about
Relative Replication Capacity and Selective Advantage Profiles of Protease Inhibitor-Resistant Hepatitis C Virus (HCV) NS3 Protease Mutants in the HCV Genotype 1b Replicon SystemProanthocyanidin from Blueberry Leaves Suppresses Expression of Subgenomic Hepatitis C Virus RNAManaging chronic hepatitis C in the difficult-to-treat patientAntiviral treatment for hepatitis C virus infection after liver transplantation.Hepatitis C viral heterogeneity based on core gene and an attempt to design small interfering RNA against strains resistant to interferon in rawalpindi, pakistan.Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse.The burden of hepatitis C virus infection is growing: a Canadian population-based study of hospitalizations from 1994 to 2004.Immune responses during acute and chronic infection with hepatitis C virus.
P2860
Q27485441-DF8E3C57-3991-44E3-B820-66D3E3ABBCE4Q27489836-1B54BFC0-4E42-416F-B29A-6310D34CB329Q27490409-FAF13FCE-0120-473C-AC84-8561C86BFB45Q34340293-8DC30439-1E64-487F-9361-E5BA64C2982BQ36142763-1B5B420A-207C-4B41-8D76-B14955801658Q37125615-EFA71071-4A61-4FEA-926C-DFBFD2025252Q37144257-129D00AA-F70C-4102-9D07-35E9A69E7020Q37178225-A412408B-E359-4879-9FC4-8DC1AEE25A53
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Future therapies for hepatitis C.
@ast
Future therapies for hepatitis C.
@en
type
label
Future therapies for hepatitis C.
@ast
Future therapies for hepatitis C.
@en
prefLabel
Future therapies for hepatitis C.
@ast
Future therapies for hepatitis C.
@en
P1433
P1476
Future therapies for hepatitis C
@en
P2093
Jean-Michel Pawlotsky
Robert G Gish
P304
P577
2006-01-01T00:00:00Z